Clinical Trials in Michigan

Showing 10281-10300 of 16,154 trials

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

NCT01490866

This is a non-randomized, open-label, Phase II trial investigating axitinib as a single-agent maintenance therapy following standard first-line FOLFOX/bevacizumab therapy for patients with mCRC.

Colorectal Cancer

SCRI Development Innovations, LLC70 participantsStarted Jan 2012

Jonesboro, Arkansas, United States • Fort Myers, Florida, United States • Pensacola, Florida, United States +9 more locations

COMPLETEDPhase 283 miles

A Study in Participants With Moderate to Severe Psoriasis

NCT01107457

The primary purpose for this study is to help answer the following research questions * The safety of ixekizumab (LY2439821) and any side effects that might be associated with it. * Whether ixekizumab can help participants with Psoriasis. * How much ixekizumab should be given to participants.

Psoriasis

Eli Lilly and Company142 participantsStarted Apr 2010

Bakersfield, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +31 more locations

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

A Study in Participants With Moderate to Severe Psoriasis

Find Trials by Condition in Michigan

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

A Study of LY3015014 in Participants With High Cholesterol

Firmagon (Degarelix) Intermittent Therapy

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

A Study in Non-Small Cell Lung Cancer

Soft Contacts Observation of Risk and Education (SCORE)

A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes